Hey folks. If you’re thinking about breaking away from the cable monopolies and getting your data, music, and video in other ways, congratulations, I’m with you. I cut the cord back in 2009, and now millions of people are doing the... Read more »
Another big move today in the race to develop self-driving cars: Delphi Automotive has inked a deal to acquire NuTonomy, an autonomous vehicle software startup, for up to $450 million.
The U.K.-based automotive supplier (NYSE: DLPH) will pay $400 million... Read more »
When hurricanes and other natural disasters strike, buildings and other physical structures aren’t the only things at risk of being destroyed. Crucial data and IT infrastructure can also be lost as a result of inclement weather, and a sector called “disaster-recovery-as-a-service”... Read more »
Kite Pharma wasn’t expecting a regulatory decision for its non-Hodgkin lymphoma treatment until November, but this week, the company got the FDA’s O.K.
The approval of axicabtagene ciloleucel (Yescarta) marks the second time in the two months that the FDA has... Read more »
The conventional wisdom about Silicon Valley is that it’s a playground for the underdogs, a fertile ground for young entrepreneurs building startups that are going to “change the world.”
Instead, the Bay Area—while, yes, still home to thirsty young entrepreneurs—is increasingly... Read more »
From Portland to Pittsburgh, it’s likely that every city in the U.S. with more than 1 million people has made its case to Amazon to locate the company’s second headquarters there.
At least, hopefully they have already, because today—if you... Read more »
For Michèle Morris, the big question hanging over organizers as they laid the groundwork last year for the first Design Forward Summit was whether the innovation community in San Diego understood the value of design.
“We didn’t know who was going... Read more »
Green Bay, WI, is among the smallest of the 30-plus cities Steve Case and other leaders of his venture capital firm Revolution have visited since 2014 as part of its national “Rise of the Rest” tour, but Case nonetheless said he... Read more »
For the second time in two months, remarkable recoveries from desperate cases of cancer have led to early approval of a cutting-edge therapy called CAR-T, which is made from a patient’s own genetically engineered cells.
More than a month before the... Read more »